Sara Isabel P. P.
- Country
- Spain
- Department
- Dermatology
Research Overview
- Long-Term Safety and Efficacy of Lebrikizumab in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis
- Long-term Extension Study of Apremilast in Pediatric Patients Aged 6-17 with Moderate to Severe Plaque Psoriasis
- J2T-MC-KGBI/DRM06-AD13: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Efficacy, Safety and Pharmacokinetics of Lebrikizumab Compared to Placebo in Participants 6 Months to <18 Years of Age with Moderate-to-Severe Atopic Dermatitis
Data & Insights
Has run more than one trial at 25 of 67 partner sites.
Specializations
Pediatric Dermatology
The investigator specializes in treating complex dermatological conditions in children and adolescents, with particular focus on atopic dermatitis and eczema management in patients from early infancy through adolescence.
- Moderate-to-severe atopic dermatitis therapy
- Topical corticosteroid treatments
- Innovative biological therapies
Their clinical interest extends to evaluating novel therapeutic approaches for pediatric skin conditions.
Autoimmune Hair Disorders
The investigator has developed expertise in treating alopecia areata in pediatric populations, focusing on children and adolescents between 6 and 18 years of age.
- Pediatric alopecia areata treatment
- JAK inhibitor therapeutics
- Age-specific treatment protocols
Their work encompasses comprehensive evaluation of targeted therapies for autoimmune-related hair loss in young patients.
Pediatric Immunology
The investigator focuses on immune-mediated skin disorders in pediatric populations, exploring the intersection of immunological responses and dermatological manifestations.
- Immune system modulation
- Pediatric immunotherapy
- Treatment resistance patterns
Their expertise includes evaluating immune response patterns in childhood dermatological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.